Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 0.62 | (41.89) | (23.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 0.62 | (57.84) | (66.40)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 17.21 | (42.07) | (67.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Corvus Pharmaceuticals leaps after launching pha... | 07-Jul-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 5.87 |
Change Today | $ -0.25 |
% Change | -4.09 % |
52 Week High | $9.56 |
52 Week Low | $2.72 |
Volume | 1,651,353 |
Shares Issued | 29.20m |
Market Cap | $171.39m |
RiskGrade | 454 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Time | Volume / Share Price |
16:00 | 830,082 @ $5.87 |
15:59 | 200 @ $5.87 |
15:59 | 100 @ $5.87 |
15:59 | 200 @ $5.87 |
15:59 | 891 @ $5.87 |
You are here: research